# US 9,433,592 B2 · Pharmaceutical or veterinary antiviral compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 9,433,592 B2
- Document ID: US9433592B2
- Status: Granted
- Kind: B2
- Application number: 13/513,877
- Filed: 2010-12-07
- Published: 2013-01-10
- Granted: 2016-09-06
- Earliest claimed: 2009-12-09
- Assignees: Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Hospices Civils De Lyon
- Applicants: Manuel Rosa-Calatrava; Jean-Jacques Diaz; Julien Textoris; Laurence Josset
- Inventors: Manuel Rosa-Calatrava; Jean-Jacques Diaz; Julien Textoris; Laurence Josset
- Web page: https://patentgrep.com/patent/US9433592B2

## CPC

- A61K 31/165: having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K 31/13: Amines {(A61K31/04 takes precedence)}
- A61K 31/135: having aromatic rings {, e.g. ketamine, nortriptyline (methadone A61K31/137)}
- A61K 31/137: Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine {or methadone}
- A61K 31/195: having an amino group
- A61K 31/215: of carboxylic acids
- A61K 31/221: with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
- A61K 31/351: not condensed with another ring
- A61K 31/404: Indoles, e.g. pindolol
- A61K 31/421: 1,3-Oxazoles, e.g. pemoline, trimethadione
- A61K 31/437: the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A61K 31/542: ortho- or peri-condensed with heterocyclic ring systems
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 31/12: Antivirals
- A61P 31/16: for influenza or rhinoviruses
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Pharmaceutical or veterinary compositions to prevent or treat viral infections, in particular to prevent or treat influenza A, B and C virus infections.

## Claims

### Claim 1

A pharmaceutical or veterinary composition comprising midodrine and oseltamivir.

### Claim 2 (depends on 1)

The pharmaceutical or veterinary composition according to claim 1, further comprising a suitable pharmaceutical carrier.

### Claim 3

A product comprising at least midodrine and oseltamivir as a combination suitable for simultaneous, separated or staggered administration.

### Claim 4

A method to treat influenza virus infections wherein a composition comprising midodrine and oseltamivir is administered to a patient in need thereof.
